BTIG analyst Thomas Catherwood downgrades Boston Properties (NYSE:BXP) from Buy to Neutral.
Reported Late Tuesday, X4 Pharmaceuticals Announces Proposed Public Offering; No Size Disclosed
X4 Pharmaceuticals, Inc. (NASDAQ:XFOR), a leader in the discovery and development of novel small-molecule therapeutics to benefit people with diseases of the immune system, announced today that it has commenced an
